Meningitis Treatment Market Size, Share, Growth, Global Analysis and Opportunity Assessment 2018-2026
Meningitis Treatment Market |
The fluid and membranes (meninges) that surround your brain and spinal cord become inflamed in meningitis. Meningitis causes swelling in the brain and spinal cord, resulting in headaches, fever, and stiff neck as symptoms. In the United States, meningitis is most usually caused by a viral infection, but it can also be caused by bacterial, parasitic, or fungal infections. In certain situations, meningitis can improve without treatment in a matter of weeks. Others are potentially lethal and require prompt antibiotic treatment.
The collaboration of the public and private sectors to enhance vaccine availability to the general population is a major driving force for the Meningitis Treatment Market growth. For example, the Global Alliance for Vaccines and Immunization (GAVIs), an international organization, brings together public and commercial sectors with the objective of providing children in the world's poorest countries with access to all of the current vaccines. Aseptic meningitis is more likely to affect people with immune-compromised conditions such HIV, cancer, diabetes, and organ transplants.
Market Segmentation
By Causative Micro-organism
- Bacterial
- Viral
- Fungal
By Treatment Type
- Antibiotic Therapy
- Adjunctive Therapy
By Vaccine Type
According to future clinical trial results, there has been a lot of activity in the vaccine R&D arena as well. However, pricing and reimbursement scenarios in some countries are limiting the worldwide meningitis market's growth. Stringent regulatory laws, as well as conservative religious beliefs in some of the world's main markets, are creating substantial barriers to the global meningitis market's expansion.
The key players operating in the meningitis treatment market include Biomed Pvt. Ltd, Novartis, Nuron Biotech, Pfizer, Baxter, Merck & Co., GSK, and Sanofi.
Source Link:
https://www.medgadget.com/2021/12/meningitis-treatment-market-detailed-in-emerging-industry-report-2021-novartis-nuron-biotech-inc-pfizer-baxter-international.html
- Meningococcal Conjugate Vaccine
- Meningococcal Polysaccharide Vaccine (MPSV4)
- Combination Vaccine
According to future clinical trial results, there has been a lot of activity in the vaccine R&D arena as well. However, pricing and reimbursement scenarios in some countries are limiting the worldwide meningitis market's growth. Stringent regulatory laws, as well as conservative religious beliefs in some of the world's main markets, are creating substantial barriers to the global meningitis market's expansion.
The key players operating in the meningitis treatment market include Biomed Pvt. Ltd, Novartis, Nuron Biotech, Pfizer, Baxter, Merck & Co., GSK, and Sanofi.
Source Link:
https://www.medgadget.com/2021/12/meningitis-treatment-market-detailed-in-emerging-industry-report-2021-novartis-nuron-biotech-inc-pfizer-baxter-international.html
Comments
Post a Comment